1 Department of Infectious Diseases, Tick-Borne Diseases Reference Center, Paris and Northern Region, General Hospital of Villeneuve-Saint-Georges, Villeneuve-Saint-Georges, France; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Lyme Borreliosis and Other Tick-Borne Diseases (ESGBOR), Basel, Switzerland; EA 7380 Dynamyc, Université Paris-Est Créteil, Ecole Nationale Vétérinaire d'Alfort, Unité de Soins Continus (Intensive Care Unit) Anses, Créteil, France. Electronic address: alice.raffetin@chiv.fr.
2 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Lyme Borreliosis and Other Tick-Borne Diseases (ESGBOR), Basel, Switzerland; Department of Infectious Diseases & the Amsterdam Institute for Immunology & Infectious Diseases, Amsterdam University Medical Center, Amsterdam, The Netherlands.
3 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Lyme Borreliosis and Other Tick-Borne Diseases (ESGBOR), Basel, Switzerland; National Reference Center for Borrelia, Institut de Bactériologie, Fédération de Médecine Translationnelle de Strasbourg, University of Strasbourg, UR3073-Pathogens Host Arthropod Vectors Interfaces, Institut Thématique Interdisciplinaire InnoVec, Strasbourg, France.
4 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Lyme Borreliosis and Other Tick-Borne Diseases (ESGBOR), Basel, Switzerland; National Reference Laboratory for Borreliosis, Division of Clinical Microbiology, Laboratory Medicine, Region Jönköping County, Sweden; Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Linköping University, Linköping, Sweden.
5 Infectious Diseases and Intensive Care Unit, Tick-Borne Diseases Reference Center, Western Region, Pontchaillou University Hospital, Rennes, France.